Regulation - Braeburn Pharmaceuticals

Filter

Current filters:

Braeburn Pharmaceuticals

Popular Filters

US FDA rejects Titan Pharma's Probuphine NDA

01-05-2013

California, USA-based Titan Pharmaceuticals (OTCBB: TTNP) has received a Complete Response Letter from…

BiotechnologyBraeburn PharmaceuticalsNeurologicalNorth AmericaPharmaceuticalProbuphineRegulationTitan Pharmaceuticals

Back to top